Articles
16 October 2024
Vol. 17 No. 2 (2025)
Health-related quality of life and clinical characteristics of hidradenitis suppurativa in a pediatric population
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
422
Views
227
Downloads
0
HTML
Authors
Hidradenitis suppurativa (HS) is a chronic, skin-immunemediated inflammatory disease (sIMID), with a high impact on quality of life (QoL). Data on clinical management, comorbidities, psychosocial burden, and psychiatric disorders in pediatric patients with HS are scarce. The aim of our study was to compare clinical characteristics and patient-reported outcome measures (PROMs) for health-related quality of life (HRQoL) in adult and pediatric patients with HS. Data were collected on 601 patients with HS, 60 of whom (10.0%) were pediatric. The psychological and HRQoL impact was generally higher in adults than children, but it was also noteworthy in pediatric patients. Early diagnosis and interventions based on education for the patients and their families and psychological support are the key to optimal disease management and adherence. Our study underlines the need for screening for HS-associated psychiatric disorders and for using age-specific tools to evaluate HRQoL. A multidisciplinary approach involving several specialists is needed, as well as liaison with primary care specialists to improve care and management of comorbidities and psychological issues in patients with HS.
Altmetrics
Downloads
Download data is not yet available.
Citations
Napolitano M, Megna M, Timoshchuk EA, et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol 2017;10:105-15.
Liy-Wong C, Pope E, Lara-Corrales I. Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol 2015;73:S36-41.
Bettoli V, Ricci M, Zauli S, et al. Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients. Br J Dermatol 2015;173:1328-30.
Choi E, Ting OX, Chandran NS. Hidradenitis suppurativa in pediatric patients. J Am Acad Dermatol 2022;86:140-7.
Palmer RA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol 2001;26:501-3.
Lopes S, Gomes N, Trindade E, et al. Hidradenitis suppurativa in a prepubertal girl. Acta Dermatovenerol Alp Pannonica Adriat 2019;28:139-41.
Deckers IE, Van der Zee HH, Boer J, et al. Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. J Am Acad Dermatol 2015;72:485-8.
Kromann CB, Ibler KS, Kristiansen VB, et al. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol 2014;94:553-7.
Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol 2015;173:1546-9.
Sampogna F, Fania L, Mastroeni S, et al. Age-specific physical and mental health status in Italian patients with hidradenitis suppurativa: a comparison with the general population. Arch Dermatol Res 2021;313:41-7.
Shavit E, Dreiher J, Freud T, et al. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2015;29:371-6.
Wright S, Strunk A, Garg A. Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa. J Am Acad Dermatol 2022;86:55-60.
Tiri H, Jokelainen J, Timonen M, et al. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol 2018;79:514-9.
McAndrew R, Lopes FCPS, Sebastian K, et al. Quality of life in hidradenitis suppurativa: A cross-sectional study of a pediatric population. J Am Acad Dermatol 2021;84:829-30.
Seivright J, Collier E, Grogan T, et al. Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: a retrospective analysis. Pediatr Dermatol 2021;38:1132-6.
Bettoli V, Cazzaniga S, Scuderi V, et al. Hidradenitis Suppurativa Epidemiology: From the First Italian Registry in 2009 to the Most Recent Epidemiology Updates - Italian Registry Hidradenitis Suppurativa Project 2. J Eur Acad Dermatol Venereol 2019;33:4-6.
Kim Y, Lee J, Kim HS, et al. Review of Scoring Systems for Hidradenitis Suppurativa. Ann Dermatol 2024;36:9-17.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) a Simple Practical Measure for Routine Clinical Use. Clin Exp Dermatol 1994;19:210-6.
Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): Initial Validation and Practical Use. Br J Dermatol 2010;132:942-9.
Goldberg DP. The Detection of Psychiatric Illness by Questionnaire. Oxford University Press; London, UK; 1972.
Brazier JE, Harper R, Jones NM, et al. Validating the SF-36health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-4.
Sampogna F, Campana I, Fania L, et al. Pain as defining feature of health status and prominent therapeutic target in patients with hidradenitis suppurativa. J Clin Med 2021;10:3648.
McAndrew R, Lopes FCPS, Sebastian K, et al. Quality of life in hidradenitis suppurativa: A cross-sectional study of a pediatric population. J Am Acad Dermatol 2021;84:829-30.
Smidt AC, Lai JS, Cella D, et al. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol 2010;146:865-9.
Rundle CW, Rietcheck H, Militello M, et al. Pediatric hidradenitis suppurativa with concomitant bipolar disorder: an underrepresented population. Dermatology 2021;237:769-70.
Andersen PL, Kromann C, Fonvig CE, et al. Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents. Int J Dermatol 2020;59:47-51.
Reichert B, Faith EF, Katya Harfmann K. Weight counseling in pediatric hidradenitis suppurativa patients. Pediatr Dermatol 2020;37:480-3.
Van Geel MJ, Maatkamp M, Oostveen AM, et al. Comparison of the dermatology life quality index and the children’s dermatology life quality index in assessment of quality of life in patients with psoriasis aged 16-17 years. Br J Dermatol 2016;174:152-7.
How to Cite
Health-related quality of life and clinical characteristics of hidradenitis suppurativa in a pediatric population. (2024). Dermatology Reports, 17(2). https://doi.org/10.4081/dr.2024.10086
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
